In mergers and acquisitions, contingent value rights (CVRs) offer future payouts tied to specific milestones, like drug approvals or revenue targets. This mechanism bridges valuation gaps, protecting buyers from overpaying while allowing sellers to benefit from future success. Investors gain upside potential with lower risk, making CVRs a strategic tool for high-stakes deals.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends